Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 2 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
17 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
POLLET MEDICAL GROUP from Koekelare, company number BE0718614107, closed financial year 2025 with a result of € 13.4 million after tax. For that financial year POLLET MEDICAL GROUP recorded revenue of € 1.6 million and equity of € 23.4 million. Compared with financial year 2024, the result moved from € -3.2 million to € 13.4 million. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 23.4 million
▲ 134% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 13.4 million
▲ still € 3.2 million loss in 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 20.9 million.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 173,323
▼ 24% vs 2024
€ 173,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,314
▲ 39% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 75.4 million
▲ 24% vs 2024
€ 6.3 million is repaid this year. At this pace the long-term loan is gone in ≈ 12 years.
€ 501,978
▲ 50% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 153 days on average.
€ 23,748
▲ 34% vs 2024
Taxes, VAT and social contributions still to pay.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 768,096 | € 1,132,785 | € 1,198,261 | € 1,551,399 | ▲ 29% |
| Profit after taxes | € 773,127 | € 3,370,935 | € -3,170,663 | € 13,422,080 | ▲ € 16.6 million |
| Equity | € 9,823,836 | € 13,194,771 | € 10,024,108 | € 23,446,189 | ▲ 134% |
| Total debts | € 58,545,229 | € 65,695,344 | € 76,362,422 | € 85,469,537 | ▲ 12% |
| Cash | € 50,593 | € 0 | - | - | |
| Retained profit | € 7,323,836 | € 10,694,771 | € 7,524,108 | € 20,946,189 | ▲ 178% |
| Bank debt | € 51,008,193 | € 52,286,684 | € 60,581,323 | € 75,374,579 | ▲ 24% |
| Balance sheet total | € 68,369,065 | € 78,890,115 | € 86,386,530 | € 108,915,726 | ▲ 26% |
| Employees (FTE) | 0 | 0 | 1 | 1 |
Key figures of POLLET MEDICAL GROUP, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to POLLET MEDICAL GROUP?
What happened at POLLET MEDICAL GROUP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Terbassenwei NV stepped down as director. NBB
- Smardix stepped down as director. NBB
- Linus stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 13.4 million. Source: NBB ↗
- Terbassenwei NV became a director. NBB
- Smardix became a director. NBB
- Linus became a director. NBB
- New establishment in Koekelare. KBO
In short
From € 773,127 profit in 2022 to € 13.4 million profit in 2025.
Paid € 888 in corporate taxes since 2022.
Best year ever: 2025, with € 13.4 million profit.
Pays suppliers within 153 days on average.
Management
The stake of POLLET WATER GROUP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
POLLET MEDICAL GROUPThe shares are held by Pollet Group (100%) and POLLET WATER GROUP (100%). It owns 100% of Hemotech Belux BV, 100% of Sterima, 100% of Hemotech, 100% of Hemotech Switzerland, 100% of Sterima Medical & Logistics Services Liège and 51% of Farmasol itself.
Directors
According to the 2025 annual accounts
Chairman of the board · represented by Pollet Sofie
since 2024 · until 2030
Managing director · represented by Taillieu Dimitri
Also active at: TERBASSENWEI, STERIMA, EURAQUA-EUROPE, UNIMID, PPG Belgium, ALTRANS, POLLET GROUP, MICRON +14 more
since 2024 · until 2030
since 2024 · until 2030
Shareholders
100%
100%
Participations
100%
100%
100%
Hemotech Switzerland
100%
Farmasol
51%
Establishments
Establishment units
Physical locations of this company
Brouwerijstraat 14
8680 Koekelare
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 17 companies are registered at this address.
All companies at this address →TERBASSENWEI same network
€ 3 million gross margin · 2025
UNIMID same network
€ -249,093 gross margin · 2025
PPG Belgium same network
€ 33.4 million revenue · 2025
ALTRANS same network
€ 824,938 gross margin · 2025
POLLET GROUP same network
€ 7.8 million revenue · 2025
+12 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0718.614.107
- VAT number
- BE 0718.614.107
- Registered office
- Brouwerijstraat 14, 8680 Koekelare
- Names & denominations
- POLLET MEDICAL GROUP · PMG
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 14 January 2019
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige technische testen en toetsen
Activiteiten op het gebied van computerconsultancy en beheer van computerfaciliteiten
Beheer van computerfaciliteiten
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Computerconsultancy-activiteiten